High glucose induces toll-like receptor expression in human monocytes Mechanism of activation

Mohan R. Dasu, Sridevi Devaraj, Ling Zhao, Daniel H. Hwang, Ishwarlal Jialal

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

OBJECTIVE-Hyperglycemia-induced inflammation is central in diabetes complications, and monocytes are important in orchestrating these effects. Toll-like receptors (TLRs) play a key role in innate immune responses and inflammation. However, there is a paucity of data examining the expression and activity of TLRs in hyperglyce- mic conditions. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression and mechanism of their induction in monocytic cells under high-glucose conditions. RESEARCH DESIGN AND METHODS-High glucose (15 mmol/l) significantly induced TLR2 and TLR4 expression in THP-1 cells in a time- and dose-dependent manner (P < 0.05). High glucose increased TLR expression, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, and nuclear factor-κB (NF- κB) p65-dependent activation in THP-1 cells. THP-1 cell data were further confirmed using freshly isolated monocytes from healthy human volunteers (n = 10). RESULTS-Pharmacological inhibition of protein kinase C (PKC) activity and NADPH oxidase significantly decreased TLR2 and TLR4 mRNA and protein (P < 0.05). Knocking down both TLR2 and TLR4 in the cells resulted in a 76% (P < 0.05) decrease in high-glucose-induced NF-κB activity, suggesting an additive effect. Furthermore, PKC-α knockdown decreased TLR2 by 61% (P < 0.05), whereas inhibition of PKC-δ decreased TLR4 under high glucose by 63% (P < 0.05). Small inhibitory RNA to p47Phox in THP-1 cells abrogated high-glucose-induced TLR2 and TLR4 expression. Additional studies revealed that PKC-α, PKC-δ, and p47Phox knockdown significantly abrogated high-glucose-induced NF-κB activation and inflammatory cytokine secretion. CONCLUSIONS-Collectively, these data suggest that high glucose induces TLR2 and -4 expression via PKC-α and PKC-δ, respectively, by stimulating NADPH oxidase in human monocytes.

Original languageEnglish (US)
Pages (from-to)3090-3098
Number of pages9
JournalDiabetes
Volume57
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint

Toll-Like Receptors
Monocytes
Glucose
Protein Kinase C
NADPH Oxidase
Interleukin-1 Receptor-Associated Kinases
Myeloid Differentiation Factor 88
Inflammation
Messenger RNA
Diabetes Complications
Innate Immunity
Hyperglycemia
Healthy Volunteers
Proteins
Research Design
Pharmacology
RNA
Cytokines

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H., & Jialal, I. (2008). High glucose induces toll-like receptor expression in human monocytes Mechanism of activation. Diabetes, 57(11), 3090-3098. https://doi.org/10.2337/db08-0564

High glucose induces toll-like receptor expression in human monocytes Mechanism of activation. / Dasu, Mohan R.; Devaraj, Sridevi; Zhao, Ling; Hwang, Daniel H.; Jialal, Ishwarlal.

In: Diabetes, Vol. 57, No. 11, 11.2008, p. 3090-3098.

Research output: Contribution to journalArticle

Dasu, MR, Devaraj, S, Zhao, L, Hwang, DH & Jialal, I 2008, 'High glucose induces toll-like receptor expression in human monocytes Mechanism of activation', Diabetes, vol. 57, no. 11, pp. 3090-3098. https://doi.org/10.2337/db08-0564
Dasu, Mohan R. ; Devaraj, Sridevi ; Zhao, Ling ; Hwang, Daniel H. ; Jialal, Ishwarlal. / High glucose induces toll-like receptor expression in human monocytes Mechanism of activation. In: Diabetes. 2008 ; Vol. 57, No. 11. pp. 3090-3098.
@article{938bfdd3789c4442a69d20aefc268020,
title = "High glucose induces toll-like receptor expression in human monocytes Mechanism of activation",
abstract = "OBJECTIVE-Hyperglycemia-induced inflammation is central in diabetes complications, and monocytes are important in orchestrating these effects. Toll-like receptors (TLRs) play a key role in innate immune responses and inflammation. However, there is a paucity of data examining the expression and activity of TLRs in hyperglyce- mic conditions. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression and mechanism of their induction in monocytic cells under high-glucose conditions. RESEARCH DESIGN AND METHODS-High glucose (15 mmol/l) significantly induced TLR2 and TLR4 expression in THP-1 cells in a time- and dose-dependent manner (P < 0.05). High glucose increased TLR expression, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, and nuclear factor-κB (NF- κB) p65-dependent activation in THP-1 cells. THP-1 cell data were further confirmed using freshly isolated monocytes from healthy human volunteers (n = 10). RESULTS-Pharmacological inhibition of protein kinase C (PKC) activity and NADPH oxidase significantly decreased TLR2 and TLR4 mRNA and protein (P < 0.05). Knocking down both TLR2 and TLR4 in the cells resulted in a 76{\%} (P < 0.05) decrease in high-glucose-induced NF-κB activity, suggesting an additive effect. Furthermore, PKC-α knockdown decreased TLR2 by 61{\%} (P < 0.05), whereas inhibition of PKC-δ decreased TLR4 under high glucose by 63{\%} (P < 0.05). Small inhibitory RNA to p47Phox in THP-1 cells abrogated high-glucose-induced TLR2 and TLR4 expression. Additional studies revealed that PKC-α, PKC-δ, and p47Phox knockdown significantly abrogated high-glucose-induced NF-κB activation and inflammatory cytokine secretion. CONCLUSIONS-Collectively, these data suggest that high glucose induces TLR2 and -4 expression via PKC-α and PKC-δ, respectively, by stimulating NADPH oxidase in human monocytes.",
author = "Dasu, {Mohan R.} and Sridevi Devaraj and Ling Zhao and Hwang, {Daniel H.} and Ishwarlal Jialal",
year = "2008",
month = "11",
doi = "10.2337/db08-0564",
language = "English (US)",
volume = "57",
pages = "3090--3098",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "11",

}

TY - JOUR

T1 - High glucose induces toll-like receptor expression in human monocytes Mechanism of activation

AU - Dasu, Mohan R.

AU - Devaraj, Sridevi

AU - Zhao, Ling

AU - Hwang, Daniel H.

AU - Jialal, Ishwarlal

PY - 2008/11

Y1 - 2008/11

N2 - OBJECTIVE-Hyperglycemia-induced inflammation is central in diabetes complications, and monocytes are important in orchestrating these effects. Toll-like receptors (TLRs) play a key role in innate immune responses and inflammation. However, there is a paucity of data examining the expression and activity of TLRs in hyperglyce- mic conditions. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression and mechanism of their induction in monocytic cells under high-glucose conditions. RESEARCH DESIGN AND METHODS-High glucose (15 mmol/l) significantly induced TLR2 and TLR4 expression in THP-1 cells in a time- and dose-dependent manner (P < 0.05). High glucose increased TLR expression, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, and nuclear factor-κB (NF- κB) p65-dependent activation in THP-1 cells. THP-1 cell data were further confirmed using freshly isolated monocytes from healthy human volunteers (n = 10). RESULTS-Pharmacological inhibition of protein kinase C (PKC) activity and NADPH oxidase significantly decreased TLR2 and TLR4 mRNA and protein (P < 0.05). Knocking down both TLR2 and TLR4 in the cells resulted in a 76% (P < 0.05) decrease in high-glucose-induced NF-κB activity, suggesting an additive effect. Furthermore, PKC-α knockdown decreased TLR2 by 61% (P < 0.05), whereas inhibition of PKC-δ decreased TLR4 under high glucose by 63% (P < 0.05). Small inhibitory RNA to p47Phox in THP-1 cells abrogated high-glucose-induced TLR2 and TLR4 expression. Additional studies revealed that PKC-α, PKC-δ, and p47Phox knockdown significantly abrogated high-glucose-induced NF-κB activation and inflammatory cytokine secretion. CONCLUSIONS-Collectively, these data suggest that high glucose induces TLR2 and -4 expression via PKC-α and PKC-δ, respectively, by stimulating NADPH oxidase in human monocytes.

AB - OBJECTIVE-Hyperglycemia-induced inflammation is central in diabetes complications, and monocytes are important in orchestrating these effects. Toll-like receptors (TLRs) play a key role in innate immune responses and inflammation. However, there is a paucity of data examining the expression and activity of TLRs in hyperglyce- mic conditions. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression and mechanism of their induction in monocytic cells under high-glucose conditions. RESEARCH DESIGN AND METHODS-High glucose (15 mmol/l) significantly induced TLR2 and TLR4 expression in THP-1 cells in a time- and dose-dependent manner (P < 0.05). High glucose increased TLR expression, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, and nuclear factor-κB (NF- κB) p65-dependent activation in THP-1 cells. THP-1 cell data were further confirmed using freshly isolated monocytes from healthy human volunteers (n = 10). RESULTS-Pharmacological inhibition of protein kinase C (PKC) activity and NADPH oxidase significantly decreased TLR2 and TLR4 mRNA and protein (P < 0.05). Knocking down both TLR2 and TLR4 in the cells resulted in a 76% (P < 0.05) decrease in high-glucose-induced NF-κB activity, suggesting an additive effect. Furthermore, PKC-α knockdown decreased TLR2 by 61% (P < 0.05), whereas inhibition of PKC-δ decreased TLR4 under high glucose by 63% (P < 0.05). Small inhibitory RNA to p47Phox in THP-1 cells abrogated high-glucose-induced TLR2 and TLR4 expression. Additional studies revealed that PKC-α, PKC-δ, and p47Phox knockdown significantly abrogated high-glucose-induced NF-κB activation and inflammatory cytokine secretion. CONCLUSIONS-Collectively, these data suggest that high glucose induces TLR2 and -4 expression via PKC-α and PKC-δ, respectively, by stimulating NADPH oxidase in human monocytes.

UR - http://www.scopus.com/inward/record.url?scp=58149333718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149333718&partnerID=8YFLogxK

U2 - 10.2337/db08-0564

DO - 10.2337/db08-0564

M3 - Article

VL - 57

SP - 3090

EP - 3098

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 11

ER -